Related Experiment Video
Updated: Jul 21, 2025
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
3.3K
Current problems in renal denervation and a hope to break the stage
Xinyu Hu1,2, Hao Zhou1,3, Weijie Chen1,3
1Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Avenue, Nan'an District, Chongqing, China.
Summary
Renal denervation (RDN) shows varied blood pressure responses due to poor patient selection. Combining 3D mapping with renal nerve stimulation (RNS) may improve RDN accuracy and patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Renal denervation (RDN) efficacy is limited by heterogeneous patient responses.
- Lack of precise patient selection and intervention endpoint detection hinders RDN success.
Purpose of the Study:
- To identify characteristics of suitable patients for RDN.
- To propose methods for enhancing the accuracy and selectivity of RDN procedures.
Main Methods:
- Review of patient characteristics for optimal RDN candidacy.
- Integration of 3D electroanatomic mapping systems for renal arteries.
- Application of modified renal nerve stimulation (RNS) techniques.
Main Results:
- Proposed a combined approach using 3D mapping and RNS for guiding RDN.
- This method aims to improve the accuracy of radiofrequency catheter ablation.
Conclusions:
- Accurate patient selection is crucial for successful RDN.
- 3D electroanatomic mapping coupled with RNS offers a promising strategy for selective and accurate RDN in clinical practice.
Keywords:
Blood pressure responseHypertensionRenal denervationRenal nerve stimulationSelective ablationMore Related Videos
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
01:25Chronic Kidney Disease I: Introduction
37
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
37
01:06Renal Drug Clearance: Overview
251
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
251
01:30Heart Failure V: Medical Management
14
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14
01:25Antihypertensive Drugs: Direct Renin Inhibitors
687
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
687
01:18Chronic Kidney Disease IV: Nursing Management
25
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
25